Detalhe da pesquisa
1.
Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTs.
Mult Scler
; 30(7): 820-832, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551315
2.
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients.
Mult Scler
; 29(14): 1841-1848, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728389
3.
The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia.
Mult Scler
; 27(6): 913-921, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33565909
4.
Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab.
JAMA Netw Open
; 7(4): e246345, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607624
5.
T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations.
Neuroimage Clin
; 34: 102967, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202997
6.
Experience of South American MS and/or NMOSD experts in practice during the COVID-19 pandemic: Focus on Telemedicine.
Mult Scler Relat Disord
; 48: 102702, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33360914
7.
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAM.
Mult Scler Relat Disord
; 51: 102886, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33744758